Log in
Enquire now
‌

US Patent 11185541 Methods for treating antipsychotic-induced weight gain

Patent 11185541 was granted and assigned to Alkermes (company) on November, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Alkermes (company)
Alkermes (company)
Current Assignee
Alkermes (company)
Alkermes (company)
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11185541
Date of Patent
November 30, 2021
Patent Application Number
16899708
Date Filed
June 12, 2020
Patent Citations Received
‌
US Patent 11707466 Immediate release multilayer tablet
0
‌
US Patent 11951111 Immediate release multilayer tablet
0
Patent Primary Examiner
‌
Shirley V Gembeh
Patent abstract

The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical antipsychotic use. The present invention provides methods of reducing antipsychotic induced weight gain, methods for suppressing food intake and reducing ghrelin levels induced by atypical antipsychotic medications in a patient.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11185541 Methods for treating antipsychotic-induced weight gain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.